药品注册申请号:020588
申请类型:NDA (新药申请)
申请人:JANSSEN PHARMS
申请人全名:JANSSEN PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 RISPERDAL RISPERIDONE SOLUTION;ORAL 1MG/ML Yes Yes AA 1996/06/10 1996/06/10 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/03/11 SUPPL-73(补充) Approval Labeling STANDARD
2021/02/12 SUPPL-71(补充) Approval Labeling STANDARD
2020/02/05 SUPPL-72(补充) Approval Labeling 901 REQUIRED
2019/01/25 SUPPL-70(补充) Approval Labeling STANDARD
2018/07/27 SUPPL-68(补充) Approval Labeling STANDARD
2017/02/23 SUPPL-66(补充) Approval Labeling 901 REQUIRED
2016/03/01 SUPPL-65(补充) Approval Labeling STANDARD
2014/04/28 SUPPL-62(补充) Approval Labeling STANDARD
2012/08/02 SUPPL-53(补充) Approval Efficacy STANDARD
2012/03/12 SUPPL-55(补充) Approval Labeling STANDARD
2011/09/24 SUPPL-54(补充) Approval Labeling STANDARD
2011/09/24 SUPPL-48(补充) Approval Labeling STANDARD
2011/08/24 SUPPL-47(补充) Approval Labeling STANDARD
2011/06/15 SUPPL-52(补充) Approval Labeling STANDARD
2010/12/01 SUPPL-51(补充) Approval Labeling 901 REQUIRED
2010/08/30 SUPPL-50(补充) Approval Labeling UNKNOWN
2010/08/30 SUPPL-49(补充) Approval Labeling UNKNOWN
2010/08/30 SUPPL-46(补充) Approval Labeling UNKNOWN
2010/08/30 SUPPL-43(补充) Approval Labeling STANDARD
2009/07/19 SUPPL-44(补充) Approval Labeling 901 REQUIRED
2008/08/14 SUPPL-42(补充) Approval Labeling STANDARD
2007/08/22 SUPPL-37(补充) Approval Efficacy PRIORITY
2007/08/22 SUPPL-36(补充) Approval Efficacy PRIORITY
2006/10/06 SUPPL-29(补充) Approval Efficacy STANDARD
2006/10/06 SUPPL-28(补充) Approval Efficacy STANDARD
2006/10/06 SUPPL-24(补充) Approval Efficacy PRIORITY
2005/08/17 SUPPL-30(补充) Approval Labeling STANDARD
2003/12/04 SUPPL-18(补充) Approval Efficacy STANDARD
2003/12/04 SUPPL-17(补充) Approval Efficacy STANDARD
2003/11/21 SUPPL-23(补充) Approval Labeling STANDARD
2003/10/29 SUPPL-16(补充) Approval Labeling STANDARD
2003/09/10 SUPPL-21(补充) Approval Labeling STANDARD
2002/11/19 SUPPL-15(补充) Approval Labeling STANDARD
2002/03/03 SUPPL-4(补充) Approval Efficacy STANDARD
2001/10/22 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1999/07/02 SUPPL-5(补充) Approval Labeling STANDARD
1998/10/08 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
1998/06/03 SUPPL-8(补充) Approval Manufacturing (CMC) STANDARD
1998/05/19 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
1998/04/02 SUPPL-1(补充) Approval Labeling STANDARD
1997/10/17 SUPPL-2(补充) Approval Efficacy UNKNOWN
1997/04/15 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
1996/06/10 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
001 4804663 2007/12/29 U-90 PDF格式**本条是由Drugfuture回溯的历史信息**
4804663*PED 2008/06/29 PDF格式**本条是由Drugfuture回溯的历史信息**
5453425 2014/07/11 PDF格式**本条是由Drugfuture回溯的历史信息**
5453425 2014/07/11 Y PDF格式**本条是由Drugfuture回溯的历史信息**
5453425*PED 2015/01/11 PDF格式**本条是由Drugfuture回溯的历史信息**
5616587 2014/07/11 PDF格式**本条是由Drugfuture回溯的历史信息**
5616587*PED 2015/01/11 PDF格式**本条是由Drugfuture回溯的历史信息**
RE39181 2014/07/11 Y PDF格式**本条是由Drugfuture回溯的历史信息**
RE39181*PED 2015/01/11 PDF格式**本条是由Drugfuture回溯的历史信息**
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
001 I-412 2006/12/04**本条是由Drugfuture回溯的历史信息**
I-413 2006/12/04**本条是由Drugfuture回溯的历史信息**
I-509 2009/10/06**本条是由Drugfuture回溯的历史信息**
I-540 2010/08/22**本条是由Drugfuture回溯的历史信息**
I-541 2010/08/22**本条是由Drugfuture回溯的历史信息**
PED 2007/06/04**本条是由Drugfuture回溯的历史信息**
PED 2010/04/06**本条是由Drugfuture回溯的历史信息**
PED 2011/02/22**本条是由Drugfuture回溯的历史信息**
与本品治疗等效的药品
活性成分:RISPERIDONE 剂型/给药途径:SOLUTION;ORAL 规格:1MG/ML 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
020588 001 NDA RISPERDAL RISPERIDONE SOLUTION;ORAL 1MG/ML Prescription Yes Yes AA 1996/06/10 JANSSEN PHARMS
076904 001 ANDA RISPERIDONE RISPERIDONE SOLUTION;ORAL 1MG/ML Discontinued No No AA 2009/07/29 HIKMA
077719 001 ANDA RISPERIDONE RISPERIDONE SOLUTION;ORAL 1MG/ML Discontinued No No AA 2009/07/29 PHARM ASSOC
078452 001 ANDA RISPERIDONE RISPERIDONE SOLUTION;ORAL 1MG/ML Prescription No No AA 2009/09/04 AUROBINDO PHARMA LTD
079158 001 ANDA RISPERIDONE RISPERIDONE SOLUTION;ORAL 1MG/ML Prescription No No AA 2010/12/03 LANNETT CO INC
090347 001 ANDA RISPERIDONE RISPERIDONE SOLUTION;ORAL 1MG/ML Prescription No No AA 2011/02/07 TARO
091384 001 ANDA RISPERIDONE RISPERIDONE SOLUTION;ORAL 1MG/ML Prescription No No AA 2011/05/25 AMNEAL PHARMS
079059 001 ANDA RISPERIDONE RISPERIDONE SOLUTION;ORAL 1MG/ML Prescription No No AA 2012/12/12 TRIS PHARMA INC
202386 001 ANDA RISPERIDONE RISPERIDONE SOLUTION;ORAL 1MG/ML Prescription No No AA 2015/01/12 CHARTWELL MOLECULAR
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database